Skip to content
Trial Eligibility
Menu

COVID-19 Pandemic Impact on Alcohol (PIA) - A Natural History Study

NCT04391816

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Background: The SARS-CoV-2 virus has caused a pandemic infection called COVID-19. It is a global threat to people, communities, and health systems. Researchers are concerned about the mental health effects of the pandemic. They want to learn more about how it is affecting people s alcohol use and problems, and how it may continue to affect them over time. Objective: To study the impact of the COVID-19 pandemic on alcohol use and consequences in individuals across the spectrum of alcohol use and those with alcohol use disorder.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Alcohol Drinking
  • Alcohol-Related Disorders
  • Pandemic
  • Psychological Stress

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
18 to 100 years
Sex
All
Healthy volunteers
Accepted
Sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Last updated on ClinicalTrials.gov
June 24, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Maryland · 1

  • NIAAA Section on Human Psychopharmacology · Bethesda, MD

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.